CBL-514 Injection

CBL-514 · Caliway Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CBL-514 Injection, covering 2024-03-28 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 ) [Phase 3]

See pricing